Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now full pipeline small index

Acute Gouty Arthritis: full-pipeline trial registry

1 of 2 indexed Acute Gouty Arthritis trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Acute Gouty Arthritis: 2 US clinical trials tracked, 1 recruiting.

Acute Gouty Arthritis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Atom Therapeutics Co., running 1 of these trials.

Enrollment posture brief

Registry condition acute-gouty-arthritis

OPEN 1 | RECR 50% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Acute Gouty Arthritis (this)50%
Open-enrollment share among volume-matched conditions near Acute Gouty Arthritis

Acute Gouty Arthritis lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Gouty Arthritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Gouty Arthritis is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Acute Gouty Arthritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
Canakinumab lyophilized powder Drug
1 trials
Canakinumab pre-filled syringe Drug
1 trials
Triamcinolone Acetonide Drug
1 trials
ABP-745 Dose B Drug
1 trials
ABP-745 Dose A Drug
1 trials
Colchicine Drug
1 trials

US sites by state

Facility locations filed on Acute Gouty Arthritis trials. A trial with sites in several states counts in each.

Georgia 2 trials
California 2 trials
Arizona 2 trials
Texas 1 trials
Oklahoma 1 trials
New Mexico 1 trials
North Carolina 1 trials
Mississippi 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Gouty Arthritis page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Gouty Arthritis condition card totals 2 registered trials; most-linked intervention Placebo; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.